Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation

BACKGROUND: Shikonin (SKN), a naphthoquinone compound, is isolated from Chinese herbal medicine Lithospermum root and has been studied as an anticancer drug candidate in human tumor models. This study is designed to investigate whether SKN can sensitize the therapeutic effect of paclitaxel (PTX) in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Chin Med
Autors principals: Wang, Zhu, Yin, Jianhua, Li, Mingxing, Shen, Jing, Xiao, Zhangang, Zhao, Yueshui, Huang, Chengliang, Zhang, Hanyu, Zhang, Zhuo, Cho, Chi Hin, Wu, Xu
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6417206/
https://ncbi.nlm.nih.gov/pubmed/30911326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13020-019-0231-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars